|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-14
|
|
pubmed:abstractText |
Metabolic syndrome and insulin resistance have been linked to increased risk of occurrence and mortality of hepatocellular carcinoma (HCC). Recently, retinol-binding protein 4 (RBP4) was clarified as a specific serological marker of insulin resistance. The aim of this study was to determine whether serum RBP4 could be used as a potential marker for predicting prognosis in patients with HCC after curative resection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1432-1335
|
|
pubmed:author |
pubmed-author:ChenJu-PingJP,
pubmed-author:DaiHai-YanHY,
pubmed-author:DaiZhiZ,
pubmed-author:HeHong-WeiHW,
pubmed-author:LUS YSY,
pubmed-author:LeeJ SJS,
pubmed-author:RenGuangG,
pubmed-author:TangGuang-YuGY,
pubmed-author:TangZhao-YouZY,
pubmed-author:WangDan-DanDD,
pubmed-author:WangFeiF,
pubmed-author:WangLuL,
pubmed-author:WangXi-LongXL,
pubmed-author:XiaZu-GuangZG,
pubmed-author:ZhangTaoT,
pubmed-author:ZhangWeiW,
pubmed-author:ZhaoYi-MingYM,
pubmed-author:ZhouJia-MinJM,
pubmed-author:ZhouJianJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
137
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
651-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20549233-Adult,
pubmed-meshheading:20549233-Aged,
pubmed-meshheading:20549233-Carcinoma, Hepatocellular,
pubmed-meshheading:20549233-Cell Line, Tumor,
pubmed-meshheading:20549233-Female,
pubmed-meshheading:20549233-Humans,
pubmed-meshheading:20549233-Liver,
pubmed-meshheading:20549233-Liver Neoplasms,
pubmed-meshheading:20549233-Male,
pubmed-meshheading:20549233-Middle Aged,
pubmed-meshheading:20549233-Prognosis,
pubmed-meshheading:20549233-Retinol-Binding Proteins, Plasma,
pubmed-meshheading:20549233-Retrospective Studies
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection.
|
|
pubmed:affiliation |
Department of Endocrinology, Punan Hospital, Shanghai 200125, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
